Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The current evidences indicate that ~30% patients with sick sinus syndrome(SSS) would develop
persistent atrial fibrillation (AF) after a long term pacing therapy. However, the accurate
influence of antiarrhythmic drugs on the AF is still not well defined. The purpose of the
study is to assess the therapeutic effects of various antiarrhythmic drugs (Amiodarone,
Sotalol and Propafenone) on the long term management of AF in SSS patients with AF, including
the reduced AF burden (duration and episodes) and persistent AF free survival rate. All
patients will be followed up for 12 months.
Phase:
Phase 4
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine